FDA Approval Precedent (for gene therapy)
**What it means:** The fact that seven AAV-based gene therapies have received FDA approval provides a regulatory pathway that the MEF2C gene therapy team can follow. FDA has extensive experience revie...
Explainers
Plain-English explanations of MEF2C research terms, concepts, and scientific mechanisms.
Oncology / Solid Tumor (in CDK2 inhibitor context)
**What it means:** Oncology is the branch of medicine that deals with cancer. "Solid tumors" are cancers that form actual lumps or masses (as opposed to blood cancers like leukemia). Breast, ovarian, ...
MADS-Box (DNA-binding domain)
**What it means:** The MADS-box is a ~58 amino acid DNA-binding domain — a specific region of the MEF2C protein that acts like a **grip** or **claw** that grabs onto specific DNA sequences. It's the p...
Isogenic (in stem cell research)
**What it means:** "Isogenic" cells are cells that are **genetically identical except for one specific difference** — like twin siblings where one has a targeted mutation and the other doesn't. Resear...
NEDHSIL (Neurodevelopmental Disorder with Hypotonia, Stereotypic Hand Movements, and Impaired Language)
**What it means:** NEDHSIL is the **alternative name** for MEF2C-associated syndrome. It describes the core clinical features without naming the gene. You might see it in older papers or clinical note...